SlimLine

|
  • 0

SlimLine

Tuesday, 13 August 2019 | Pioneer

MedGenome Labs has developed SPIT SEQ, the first whole genome sequencing based test that can provide a detailed analysis of every single mutation present in any tuberculosis bacteria causing drug resistance-directly from the sputum. This break-through will enable a doctor to quickly and accurately prescribe the most effective drug to a tuberculosis patient without a trial and error process, followed currently that takes a month.

India has the largest number of multi drug resistant (MDR-TB) TB cases. SPIT SEQ can be a boon for TB patients, clinicians and healthcare agencies to achieve India’s Sustainable Development Goal (SDG) of elimination TB by 2025. The test is based on whole genome sequencing of mycobacterium tuberculosis (MTB), the TB causing bacteria, to assess the mutations in bacteria’s genome and allows a clinician to determine which drugs will work for a patient.

State Editions

SC OK’s admission in 3 new medical colleges

20 August 2019 | PNS | Ranchi

15 IAS officers shifted in State’

20 August 2019 | PNS | Ranchi

3 from Odisha in Jr women’s hockey coaching camp

20 August 2019 | PNS | Bhubaneswar

Food bank for ‘Hunger-Fee Odisha’ opened

20 August 2019 | PNS | Bhubaneswar

MCL holds pipping ceremony

20 August 2019 | PNS | Bhubaneswar

Sunday Edition

Game on!

18 August 2019 | Pioneer | Agenda

Krishna, the nation builder

18 August 2019 | Dr. Asha Goswami | Agenda

Happiness in digital world

18 August 2019 | Dr Awdhesh Singh | Agenda

Faith does more than heal

18 August 2019 | Ajit Kumar Bishnoi | Agenda

Astroturf | Let love play the game changer

18 August 2019 | Bharat Bhushan Padmadeo | Agenda

Art for the soul

18 August 2019 | Shalini Saksena | Sunday Pioneer